Status | Study |
NOT_YET_RECRUITING |
Study Name: Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma Condition: Date: 2023-06-15 Interventions: Daratumumab SC (daratumumab and hyaluronidase) is administered subcutaneously (SC) as 1800 mg/30,000 units weekly for a total of 8 weeks (8 doses |
Not yet recruiting |
Study Name: Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas Condition: Activated B-Cell-Like Diffuse Large B-Cell Lymphoma ALK-Positive Large B-Cell Lymphoma Date: 2017-01-31 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma Condition: Primary Effusion Lymphoma B-Cell Lymphoma Date: 2016-09-21 Interventions: Drug: Lenalidomide Lenalidomid |
Recruiting |
Study Name: Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies Condition: B-cell Non-Hodgkins Lymphoma Chronic Lymphocytic Leukemia Date: 2016-09-14 Interventions: Biological: XmAb13676 Biological |
Recruiting |
Study Name: Clinical Factors and Gene Expression Analysis for Prognosis in Tissue Samples From Patients With AIDS-Related Primary Effusion Lymphoma Condition: AIDS-Related Primary Effusion Lymphoma Date: 2016-07-01 Interventions: Genetic: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma Condition: Adult Nasal Type Extranodal NK/T-Cell Lymphoma Adult T-Cell Leukemia/Lymphoma Date: 2016-01-08 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma Condition: AIDS-Related Burkitt Lymphoma AIDS-Related Diffuse Large B-cell Lymphoma Date: 2014-12-23 Interventions: Drug: Prednisone Given PO |
Withdrawn |
Study Name: Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas Condition: Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease Date: 2014-08-27 Interventions: Drug: Pomalidomide Part A: 5 m |
Recruiting |
Study Name: Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma Condition: AIDS-related Non-Hodgkin Lymphoma AIDS-related Plasmablastic Lymphoma Date: 2013-09-09 Interventions: Drug: busulfan Given IV |
Active, not recruiting |
Study Name: Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas Condition: AIDS-Related Diffuse Large Cell Lymphoma AIDS-Related Plasmablastic Lymphoma Date: 2010-09-01 Interventions: Drug: Cyclophosphamide Given I |